CNE100003P25
CNE100003P25
QINGDAO HAIER BIOMEDICAL CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.328.672.376 | 2.283.832.911 | 2.0% |
| Cost of Revenue | 1.239.105.143 | 1.187.914.555 | 4.3% |
| Gross Profit | 1.089.567.233 | 1.095.918.357 | 0.6% |
| 855.245.320 | 752.550.492 | 13.6% | |
| Operating Income | 234.321.913 | 343.367.864 | 31.8% |
| Pretax Income | 264.759.973 | 401.956.705 | 34.1% |
| Net Income Common Stockholders | 250.730.797 | 366.632.797 | 31.6% |
| -- | -- | -- | |
| -- | -- | -- |